Clinical Trial Update: Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

Multicenter Phase 2 trial comparing R-CHOP versus R-COP in patients with Diffuse Large B-Cell Lymphoma to assess cardiotoxicity; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: COMPLETED